Cervical cancer

There are 503 papers on cervical cancer in aging research: 15 trials and 270 observational studies in people, 2 in animals, 11 in cells, 140 reviews.

Disease

503 papers study it216 more mention it93 findings

81 new papers in 30 daysSee all 719 papers on cervical cancer

At a glance

Cervical cancer is linked with older age and poorer recall in human studies, and with lower cellular senescence than cervical intraepithelial neoplasia in human tissue. Human cohorts associate HPV vaccination with lower cervical cancer risk, while a screening implementation study reports less advanced-stage disease; reviews also describe prevention through vaccination and screening.

93 findings in 76 papers from 2016 to 2026, 34 of them since April 2026

“cervical cancer (HR, 1.31; 95% CI, 1.13-1.51, p < 0.001)”
Vitamin D deficiency and long-term risk of female genital cancer: a multicenter real-world cohort studyFrontiers in nutrition2026doi:10.3389/fnut.2026.1903301
  • Human trial15
  • Humans270
  • Animals2
  • Cells11
  • In silico62

Interventions

10

Cervical cancer screening

downin humans3−43%

3 studies
  1. Cervical cancer screening is linked with lower cervical cancer in humans (advanced-stage (III-IV) disease after KOFIH and UNFPA/UNDP implementation) (-43%).

    “while the proportion of advanced-stage (III-IV) disease declined by 43%”

    Humansadvanced-stage (III-IV) disease after KOFIH and UNFPA/UNDP implementationcervixfemalesn = 2,140

    Population‑based registry analysis of cervical cancer trends in Tashkent Uzbekistan 2014-2024

    JNCI cancer spectrum

  2. Cervical cancer screening decreases cervical cancer in humans (national roll-out of Programme ZORA).

    “Cervical and colorectal cancer incidence and mortality are decreasing”

    Reviewnational roll-out of Programme ZORA

    Why Organised Cancer Screening Works: Lessons from Slovenia and the Next Phase of Evidence-Based Implementation

    Zdravstveno varstvo

  3. Cervical cancer screening prevents cervical cancer in humans.

    “Current guidelines do not adequately address these changes, and may be missing significant opportunities to prevent cervical cancer cases and deaths in older women.”

    Reviewfemales

    It's time to re-evaluate cervical Cancer screening after age 65

    Gynecologic oncology

More on Cervical cancer screening

Smoking

no changein humans1

1 study
  1. Smoking was not clearly linked with cervical cancer in humans (East Asian populations).

    “MR analysis did not identify statistically significant causal associations between any smoking-related exposure factors and CC risk”

    HumansEast Asian populations

    Epidemiological characteristics of cervical cancer in Asian populations and risk factor inference based on Mendelian randomization

    Medicine

More on Smoking

Vaccination

downin humans1

1 study
  1. Vaccination prevents cervical cancer in humans (for HPV- and HBV-related cancers).

    “HPV- and HBV-related cancers are largely preventable through vaccination, although coverage remains uneven across Asia.”

    Reviewfor HPV- and HBV-related cancers

    Infection-driven cancers in Asia: implications from epidemiological transitions

    The Lancet regional health. Western Pacific

More on Vaccination

HPV vaccination

downin humans1

1 study
  1. HPV vaccination prevents cervical cancer in humans.

    “Cervical cancer remains a leading cause of cancer-related mortality among women, despite being largely preventable through Human Papillomavirus (HPV) vaccination, HPV screening, and treatment.”

    Reviewcervixfemales

    Challenges and possible solutions towards reaching global cervical cancer elimination

    EClinicalMedicine

More on HPV vaccination

LY3177833 + paclitaxel

downin mice1

1 study
  1. LY3177833 + paclitaxel decreases cervical cancer in vivo xenograft models.

    “in vivo models validating suppressed tumor growth”

    Animalsin vivo xenograft models

    A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer

    Translational cancer research

More on LY3177833 + paclitaxel

HPV vaccine

downin humans1

1 study
  1. HPV vaccine prevents cervical cancer in humans (no new cases).

    “no new cases of cervical cancer have been detected in a cohort of Scottish women vaccinated against HPV between 12-13 years old”

    Reviewcervixfemales

    Prevention and Diagnosis of Cervical Cancers in the UK and Europe: What Have We Learned in the Last 10 Years and What Is Next?

    British journal of hospital medicine (London, England : 2005)

More on HPV vaccine

Self-collection cervical screening

no changein humans1OR 0.71

1 study
  1. Self-collection cervical screening was not clearly linked with cervical cancer in humans (women referred for colposcopy with HPV 16/18) (adjusted OR 0.71, 95% CI 0.36-1.40).

    “Histological detection of cancer was similar between self-collected and clinician-collected samples, both for those with HPV 16/18 (adjusted OR 0·71 [95% CI 0·36-1·40])”

    Humanswomen referred for colposcopy with HPV 16/18self-collected vs clinician-collected samplesfemales

    Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort study

    The Lancet. Public health

More on Self-collection cervical screening

Screening

downin humans1

1 study
  1. Screening prevents cervical cancer in humans.

    “the disease can be prevented by screening”

    Review

    Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes

    Current topics in microbiology and immunology

More on Screening

Early menopause

no changein humans1

1 study
  1. Early menopause was not clearly linked with cervical cancer in humans (aOR 1.435, 95% CI 0.730-2.821).

    “There was no association between early menopause and cervical cancer (adjusted odds ratio [aOR]: 1.435, 95% confidence interval [CI]: 0.730-2.821)”

    Humansfemalesn = 4,481

    Association between Early Menopause, Gynecological Cancer, and Tobacco Smoking: A Cross-Sectional Study

    Asian Pacific journal of cancer prevention : APJCP

More on Early menopause

Repeat cytology

no changein humans1

1 study
  1. Repeat cytology was not clearly linked with cervical cancer in humans (Incidence rate ratio 1.1, 95% CI 0.5–2.5).

    “had a similar risk of cervical cancer compared with colposcopy/biopsy”

    HumansAfter atypical squamous cells of undetermined significance; compared with colposcopy/biopsycervixWithin 6 monthsfemales

    Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study

    American journal of obstetrics and gynecology

More on Repeat cytology

Effects

3

SAT1

upin human cells1

1 study
  1. Cervical cancer increases SAT1 in human cells.

    “We identified elevated expression of the rate-limiting SPD metabolic enzyme SAT1 in cervical cancer tissues.”

    Cellscervical cancer tissues

    SAT1-Mediated Spermidine Metabolism Drives Ferroptosis in Cervical Cancer

    Research SquarePreprint

More on SAT1

Mortality

upin humans1

1 study
  1. Cervical cancer is linked with higher mortality in humans (China, 2000-2020) (AAPC = 3.9%).

    “while the ASMR rose steadily (AAPC = 3.9%).”

    HumansChina, 2000-20202000-2020females

    Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals

    Cancer biology & medicine

SERPINE1

upin human cells1

1 study
  1. Cervical cancer increases SERPINE1 in cervical cancer cells and tissues.

    “In vitro studies showed increased SERPINE1 and IL-1α ((genes included in the signature) expression in CC cells and tissues”

    Cellsin cervical cancer cells and tissues

    A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity

    Research squarePreprint

More on SERPINE1

Upstream

5

Time

downin humans1

1 study
  1. time is linked with lower cervical cancer in humans (cervical cancer burden across 34 Asian countries from 1990 to 2023).

    “From 1990 to 2023, ASIR and ASDR generally declined across Asia, although substantial regional disparities persisted.”

    Humanscervical cancer burden across 34 Asian countries from 1990 to 2023females

    Age-specific burden of cervical cancer and attributable risk factors in Asia, 1990-2023: A global burden of disease study 2023

    European journal of obstetrics, gynecology, and reproductive biology

Later menopause

no changein humans1

1 study
  1. Later menopause was not clearly linked with cervical cancer in humans.

    “but not cervical cancer, confirming distinct human papillomavirus (HPV)-driven etiology”

    Humansfemalesn = 143,819

    Global burden trends and menopause timing associations for gynecological and breast cancers in postmenopausal women

    iScience

Senescence-associated secretory phenotype (SASP)

mediatesin humans1

1 study
  1. Senescence-associated secretory phenotype (SASP) mediates cervical cancer in humans (cervical epithelial neoplasia cells).

    “biological basis of CIN progression via SASP senescence and ultimately EMT”

    Reviewcervical epithelial neoplasia cells

    HPV Infection and Oxidative Stress in Cervical Carcinogenesis: Linking Apoptosis, Senescence, SASP, and EMT

    Antioxidants (Basel, Switzerland)

More on Senescence-associated secretory phenotype (SASP)

Older-adults

upin humans1

1 study
  1. Older-adults are linked with higher cervical cancer in humans (rural and urban China).

    “In contrast, women ≥65 y of age had a steadily increasing incidence and mortality in rural and urban areas.”

    Humansrural and urban China2000-2020females

    Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals

    Cancer biology & medicine

HIV infection

no changein humans1

1 study
  1. HIV infection was not clearly linked with cervical cancer in humans (1.4% in both groups).

    “In both groups, 1.4% developed cervical cancer.”

    Humansfemalesn = 140

    Pap smear outcomes in elderly women living with HIV and HIV-negative matched controls

    International journal of STD & AIDS

More on HIV infection

Associations

53

HPV vaccine

downin humans5downin silico2

7 studies
  1. HPV vaccine is linked with a lower risk of cervical cancer in humans (-1.45 cases per 100,000 population).

    “Cervical cancer incidence declined by 1.45 cases per 100,000 population (CI= -1.76, -1.15)”

    Humansfemales

    Heterogeneous Population-level Cervical Cancer Reductions Following Introduction of HPV Vaccine

    Research SquarePreprint

  2. HPV vaccine is linked with a lower risk of cervical cancer in humans (screened women (vaccine-eligible)).

    “The reduction in invasive cervical cancer incidence was significantly greater than those observed for CIN2 + and CIN3 +.”

    Humansscreened women (vaccine-eligible)females

    Impact of HPV vaccination on cervical precancer and invasive cervical cancer twelve years after vaccine introduction in the Brazilian Public Health System

    Journal of infection and public health

  3. HPV vaccine lowers the risk of cervical cancer in silico (1.82 million cases averted (53% reduction)).

    “Continuation of Nigeria's current adolescent program is projected to avert 1.82 million cervical cancer cases (IQR 1.65-1.90 million; 95% UI 1.39-2.02 million) over 2025-2100 (a 53% reduction relative to no vaccination”

    In silico2025-2100

    Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria

    medRxivPreprint

  4. HPV vaccine lowers the risk of cervical cancer in humans.

    “Population-based evidence demonstrated reduced cervical cancer incidence among women vaccinated before adolescence.”

    Reviewfemales

    Human Papillomavirus (HPV) and Cervical Cancer: An Exploratory Systematic Review of Heterogeneous Evidence on Epidemiology, Vaccination, Screening, and Molecular Advances

    Cancer investigation

  5. HPV vaccine lowers the risk of cervical cancer in vaccinated populations.

    “reductions of cervical precancer and cancer incidence in vaccinated populations”

    Reviewin vaccinated populations

    How to evaluate and select cervical screening and triage tests in vaccinated populations

    Journal of the National Cancer Institute. Monographs

  6. HPV vaccine lowers the risk of cervical cancer in silico (postpartum period) (27 fewer cases).

    “and 27 fewer cases of early-stage cervical cancer in our simulated population”

    In silicopostpartum periodcervixfemalesn = 400,000

    Cost-Effectiveness of an HPV Vaccination Program in the Postpartum Period

    Journal of women's health (2002)

  7. HPV vaccine lowers the risk of cervical cancer in humans.

    “HPV vaccination reduces the risk of cervical and other cancers”

    Review

    Cancer Prevention Must Begin Earlier: A Life-Course Perspective

    Developmental medico-life-sciences

More on HPV vaccine

Human papillomavirus infection

upin humans4

4 studies
  1. Human papillomavirus infection is linked with a higher risk of cervical cancer in humans (AAPC 5.89% (95% CI: 2.82-9.06)).

    “From 1988 to 2017, the ASRs increased for HPV-attributable cervical cancer (females; average annual percent change [AAPC] and 95% CI: 5.89% [2.82-9.06])”

    Humansfemales

    Geographic and temporal variations in cancer incidence attributable to human papillomavirus infection in China: a population-based study

    BMC public health

  2. Human papillomavirus infection is associated with cervical cancer in humans (HPV detection in tumor tissue versus CIN) (61% of tumor tissues vs 25% of CINs HPV-positive).

    “Infection of HPV was confirmed in 61% of the tumor tissues while only 25% of the CINs were positive for HPV.”

    HumansHPV detection in tumor tissue versus CINcervixn = 37

    Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue

    BMC cancer

  3. Human papillomavirus infection raises the risk of cervical cancer in humans (Causes nearly all cervical cancers).

    “Persistent high-risk HPV infection causes nearly all cervical cancers, predominantly HPV16/18, with regional variation in other types.”

    Reviewpersistent high-risk infectionfemales

    Cervical Cancer Epidemiology: Global Incidence, Mortality, Survival, Risk Factors, and Equity in HPV Screening and Vaccination

    Journal of clinical medicine

  4. human papillomavirus infection is associated with cervical cancer in humans.

    “Human papillomavirus (HPV) infection is the most common sexually transmitted disease associated with the development of cervical intraepithelial neoplasia and cervical cancer”

    Review

    HPV infection and its significance in the development and prevention of cervical cancer

    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

More on Human papillomavirus infection

Unsafe sex

upin humans3

3 studies
  1. Unsafe sex is associated with cervical cancer in humans (low-SDI regions; risk attribution analysis) (>90% of cervical cancer risk).

    “unsafe sex (accounting for >90% of cervical cancer risk)”

    Humanslow-SDI regions; risk attribution analysis

    Global, regional and national cancer burden and trends of middle-aged and older populations: a GBD 2021-based analysis, prediction and prevention

    Frontiers in oncology

  2. unsafe sex is linked with a higher risk of cervical cancer in humans (cervical cancer burden in Asia).

    “Cervical cancer burden attributable to unsafe sex showed the highest DALY rate among females aged 50-69 years and the highest mortality rate among those aged 70 years or older.”

    Humanscervical cancer burden in Asiafemales

    Age-specific burden of cervical cancer and attributable risk factors in Asia, 1990-2023: A global burden of disease study 2023

    European journal of obstetrics, gynecology, and reproductive biology

  3. Unsafe sex is linked with a higher risk of cervical cancer in humans (leading risk factor).

    “Unsafe sexual practices are the leading risk factor for cervical cancer, dietary risks for breast cancer, and high body mass index for uterine and ovarian cancers.”

    Humansleading risk factorfemales

    Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

More on Unsafe sex

Cervical cancer screening

downin humans1upin humans1downin silico1

3 studies
  1. Cervical cancer screening is associated with cervical cancer in humans (ρ = 0.85, p < 0.001).

    “Correlation analysis revealed strong positive associations between higher screening coverage and the deceleration of incidence (ρ = 0.85, p < 0.001)”

    Humansfemales

    Cervical Cancer Incidence and Mortality Trends in China: The Role of Screening

    Cancer letters

  2. Cervical cancer screening is associated with cervical cancer in humans (83 cases vs around 64).

    “In 2009-2016, number of incident cervical cancers in women aged 70+ in Denmark fluctuated around 64; in 2017 it reached 83 cases”

    Humansfemales

    A cervical screening initiative for elderly women in Denmark

    Acta obstetricia et gynecologica Scandinavica

  3. Cervical cancer screening lowers the risk of cervical cancer in silico (WHO targets scale-up (70% aggregate)) (~387K cases averted).

    “Scaling up screening to WHO targets was estimated to avert a further ~387K cases (IQR 331-424K; 95% UI 269-515K), roughly 25% of the residual burden”

    In silicoWHO targets scale-up (70% aggregate)2025-2100

    Model-based evaluation of an infant HPV prophylactic vaccination program in Nigeria

    medRxivPreprint

More on Cervical cancer screening

Age

upin humans3

3 studies
  1. Age is linked with a higher risk of cervical cancer in humans (aOR 1.043, 95% CI 1.004–1.083).

    “increasing age (adjusted OR [aOR] = 1.043, 95% CI: 1.004–1.083; P = 0.030)”

    Humansfemales

    Factors associated with cervical cancer among women in northeastern Iran: a population-based case–control study

    Research SquarePreprint

  2. Age is associated with cervical cancer in humans (38.2% abnormality rate, 5.1% carcinoma detection).

    “The 51-60 years age group demonstrated the highest abnormality rate (38.2%) and carcinoma detection (5.1%).”

    Humanscervixfemalesn = 5,067

    Age-wise analysis of cervical cytology using the bethesda system: A five-year retrospective study from a tertiary care center

    International Journal of Clinical and Diagnostic Pathology

  3. Age is associated with cervical cancer in humans (95 cases per 100,000).

    “Cervical cancer incidence peaked in women aged 55-59 (95 cases per 100,000)”

    Humansfemales

    Epidemiology and prevention of HPV-driven cervical cancer in urban-rural China: a population-based study of 60,280 women

    Scientific reports

HIV infection

downin humans1upin humans1

2 studies
  1. HIV infection is associated with cervical cancer in humans (hysterectomy-corrected, 2015-2019 vs 2001-2004) (IRR=0.78, 95%CI: 0.63,0.97).

    “Compared with 2001-2004, corrected ASIRs were lower in 2005-2009 (IRR=0.79, 95%CI: 0.65,0.96); 2010-2014 (IRR=0.75, 95%CI: 0.61,0.91); and 2015-2019 (IRR=0.78, 95%CI: 0.63,0.97).”

    Humanshysterectomy-corrected, 2015-2019 vs 2001-2004cervixfemalesn = 933

    Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019

    Journal of the National Cancer Institute

  2. HIV infection raises the risk of cervical cancer in humans (approximately three times).

    “WLHIV face approximately three times the cervical cancer incidence of HIV-negative women”

    Reviewfemales

    Cervical Cancer Screening in Women Living with HIV in South Africa: Addressing Health Disparities Through Integrated Prevention Strategies

    International journal of women's health

More on HIV infection

Older age

upin humans2RR 4.11

2 studies
  1. Older age is linked with a higher risk of cervical cancer in humans (compared with participants aged <45 years) (aRR 5.02, 95% CI 2.43-10.35).

    “5.02 (2.43-10.35) for cervical cancer”

    Humanscompared with participants aged <45 years

    From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China

    Frontiers in public health

  2. Older age is linked with a higher risk of cervical cancer in humans (squamous cell abnormalities in Pap smear) (RR 4.11, 95% CI: 3.72-4.54).

    “For cervical cancer (RR 4.11, 95% CI: 3.72-4.54), the diagnosis rate was significantly higher in women over 70.”

    Humanssquamous cell abnormalities in Pap smearfemalesn = 450,349

    Analysis of Diagnosis Rate and Factors Influencing the Implementation of Confirmatory Tests in Women with Epithelial Abnormalities of Squamous Cells in Pap Tests: 5 years follow-up using the National Health Insurance Service database

    Research SquarePreprint

Human papillomavirus vaccine

downin humans2

2 studies
  1. Human papillomavirus vaccine lowers the risk of cervical cancer in humans.

    “vaccines have the anticipated effect against infection, lesions, and ultimately invasive cervical cancer”

    Review

    How practically feasible is tailored screening for cervical cancer based on human papillomavirus vaccination status?: the role of data linkage and registers

    Journal of the National Cancer Institute. Monographs

  2. Human papillomavirus vaccine lowers the risk of cervical cancer in humans.

    “has been shown to reduce the incidence and mortality of cervical cancer”

    Review

    HPV infection and its significance in the development and prevention of cervical cancer

    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

More on Human papillomavirus vaccine

HPV self-sampling

downin humans2

2 studies
  1. HPV self-sampling is linked with a lower risk of cervical cancer in humans (-27% (7.7/100,000 in 2024 vs 11-12 per 100,000 in 2015-2020)).

    “A rapid introduction of primary HPV self-sampling at home in 2020-2021 was followed by a rapid decline in invasive cervical cancer incidence.”

    Humansfemales

    Population-based cervical screening with Human Papillomavirus self-sampling at home and incidence of cervical cancer in Sweden

    Preventive medicine

  2. HPV self-sampling is linked with a lower risk of cervical cancer in humans (nationwide switch to primary screening) (7.7/100,000 in 2024 (-27% in all ages)).

    “From 2021 and onwards the incidence is declining and was 7,7/100,000 in 2024.”

    Humansnationwide switch to primary screeningfemales

    Population-based cervical screening with Human Papillomavirus self-sampling at home and incidence of cervical cancer

    medRxivPreprint

More on HPV self-sampling

Ulcerative colitis

no changein humans1upin humans1HR 1.56–3.65

1 study
  1. Ulcerative colitis is associated with cervical cancer in humans with reference to the control group (HR 1.56 (95% CI 0.97-2.50)).

    “The adjusted HR for cervical cancer was 1.56 (95% CI 0.97-2.50) in the UC group with reference to the control group.”

    Humanswith reference to the control groupfemales

    Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea

    Scientific reports

  2. Ulcerative colitis is linked with a higher risk of cervical cancer in humans (elderly UC patients (≥ 60 years) compared to elderly control group) (HR 3.65 (95% CI 1.54-8.66)).

    “adjusted HR for cervical cancer was 3.65 (95% CI 1.54-8.66) in elderly UC patients (≥ 60 years) compared to elderly control group (≥ 60 years)”

    Humanselderly UC patients (≥ 60 years) compared to elderly control groupfemales

    Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea

    Scientific reports

More on Ulcerative colitis

All 53

Trial sponsors

Funding

189 grants since 2016

National Cancer Institute$148MNational Institute on Minority Health and Health Disparities$7.3MCancer Prevention and Research Institute of Texas$25.3M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    In humans, older age and human papillomavirus infection increase cervical cancer risk, while smoking shows no effect in an East Asian cohort. Reviews link HPV vaccination to lower risk in females, supported by computational modeling of vaccination and screening.

  2. Summary written from the findings.

Latest

Dec 2025: 13Jan 2026: 46Feb 2026: 57Mar 2026: 42Apr 2026: 14May 2026: 13Jun 2026: 17Jul 2026: 25Aug 2026: 86Sep 2026: 64Oct 2026: 72Nov 2026: 39488 papers in 12 months

See all 719 papers on cervical cancer